Relapse in Previously Irradiated Prostate Bed : Stereotactic Ablative Reirradiation Potentiated by Metformin
Status:
Recruiting
Trial end date:
2028-11-01
Target enrollment:
Participant gender:
Summary
This phase I/II escalation dose study is assessing the efficacy of the recommended dose of
stereotactic re-irradiation (SBRT) of relapses within the prostatectomy bed, potentiated by
metformin